30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

Company Revenue 2015: Anika Therapeutics

2015: $73.2MM, +18% 4Q15: $21.5MM, +63% Received $5MM milestone revenue for reaching target MONOVISC U.S. end-user sales of $50MM Full-year...

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.